Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

IMMOBILE

K-Number: K915565 · 1992-03-02

Decision Date1992-03-02
Product CodeKGX
Advisory CommitteeHO
DecisionSubstantially Equivalent

Device Summary

IMMOBILE is the device name listed in this FDA 510(k) record. The listed applicant is Tnt Moborg Intl. , Ltd.. It received FDA 510(k) clearance on 1992-03-02 under 510(k) number K915565. The device is classified under product code KGX. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the IMMOBILE?

IMMOBILE is a medical device that received FDA 510(k) clearance on 1992-03-02. The listed applicant is Tnt Moborg Intl. , Ltd.. The 510(k) number is K915565.

When did IMMOBILE receive FDA 510(k) clearance?

IMMOBILE received FDA 510(k) clearance on 1992-03-02, under 510(k) number K915565.

Who is the listed applicant for IMMOBILE?

The FDA 510(k) record lists Tnt Moborg Intl. , Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for IMMOBILE?

The FDA product code for IMMOBILE is KGX.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Tnt Moborg Intl. , Ltd. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: KGX)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑